TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
SMMT

Summit Therapeutics PLC

Healthcare · Biotechnology

15.60$ -4.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Summit Therapeutics PLC (SMMT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 752 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SMMT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
180 161 141 270 384 348 297 195 262 557 491 752
168 150 130 260 374 339 287 183 246 535 468 721
20 57 49 22 72 84 164 177 239 167 81 419
164 147 125 257 371 330 280 177 – 529 454 691
0.7 0.7 0.8 0.8 0.5 0.4 – – – – – –
5.1 2.4 0.3 – 0.7 – – – – – – –
1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 2.0 1.5 1.5 2.0
98 99 106 116 50 37 31 52 69 69 77 122
93 16 19 111 45 33 27 48 65 54 63 104
84 2.2 2.9 82 22 3.0 2.7 2.0 – 2.5 2.4 3.6
2.7 2.1 5.1 2.6 2.5 3.7 3.9 17 22 15 21 23
100 100 100 – – – – – – – – –
82 61 35 154 334 311 267 143 192 489 414 630
-786 -786 -826 -867 -880 -971 -989 -1,542 -2,075 -1,703 -1,883 -2,699
698 701 702 708 727 738 738 743 744 766 775 778

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?